about
Tumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surfaceQuantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness.Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.Clinical significance of subtype classification in metastatic lymph nodes of breast cancer patients undergoing neoadjuvant chemotherapy.Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging18F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.Increased centrosome number in BRCA-related breast cancer specimens determined by immunofluorescence analysis.Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer.A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECQuantitative analyses of amount and localization of radiosensitizer gold nanoparticles interacting with cancer cells to optimize radiation therapyThe 10-Min Holistic Self-Care for Patients with Breast Cancer-Related Lymphedema: Pilot Randomized Controlled StudyReproductive history and breast cancer survival: a prospective patient cohort study in Japan
P50
Q34447829-45FA9DB8-39A9-4854-8AB9-EAA34B242D98Q36030405-F50AB093-B876-4197-99AB-9B00895ACCB3Q37403163-EF67A60C-E77B-49C0-9971-75CDE70AB9C1Q38633233-7264BA51-8CAF-4981-AA53-4A7CA2209E62Q39043672-B8935023-9A0F-4134-855F-36CF3FD64CC0Q41582791-4A543A8A-D503-4B2A-93AE-3EBD24E95EA8Q41601026-50CF3556-B27D-4CC9-8024-B2E96DBBDE2BQ47346434-004212D2-1F80-46DB-BBBB-A4C11D255CB5Q50205753-DA4754CB-0542-4770-B032-15CBD484377DQ51758191-D2E6691B-B41A-4F12-8507-B6693A6EE3A5Q64977877-828E7C59-F013-4A8F-B203-415E700F7E7AQ90313209-642D954F-513F-4000-8883-E618C45C9701Q90519043-28CFD69E-50E1-411A-A273-318D98F5E5B9Q91867213-5786576A-DFF4-4871-9A7E-A49BB640D501Q93145121-C767BE8C-1F2E-4C2D-B759-E81EC421951F
P50
description
researcher
@en
name
Hiroshi Tada
@en
type
label
Hiroshi Tada
@en
prefLabel
Hiroshi Tada
@en
P31
P496
0000-0003-2670-8982